Jump to content

Antiprotozoal

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by EmausBot (talk | contribs) at 20:15, 11 May 2012 (r2.7.2+) (Robot: Modifying ast:Antiprotozoariu). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Antiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection.

Protozoans have little in common with each other (for example, Entamoeba histolytica is less closely related to Naegleria fowleri than it is to Homo sapiens) and so agents effective against one pathogen may not be effective against another. However, metronidazole is selective for anaerobic organisms, and so it is effective against many (though not all) of these pathogens.

They can be grouped by mechanism[1] or by organism.[2]


Examples

References

  1. ^ Cynthia R. L. Webster (15 June 2001). Clinical pharmacology. Teton NewMedia. pp. 86–. ISBN 978-1-893441-37-8. Retrieved 2 May 2010.
  2. ^ Anthony J. Trevor; Bertram G. Katzung; Susan B. Masters (11 December 2007). Katzung & Trevor's pharmacology: examination & board review. McGraw-Hill Professional. pp. 435–. ISBN 978-0-07-148869-3. Retrieved 2 May 2010.